{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T11:48:47Z","timestamp":1792842527733,"version":"4.5.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Urol Nephrol"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1007\/s11255-017-1756-y","type":"journal-article","created":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T06:19:26Z","timestamp":1512109166000},"page":"97-103","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["The effect of l-thyroxine substitution on oxidative stress in early-stage diabetic nephropathy patients with subclinical hypothyroidism: a randomized double-blind and placebo-controlled study"],"prefix":"10.1007","volume":"50","author":[{"given":"Yong","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ganlin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meirong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,12,1]]},"reference":[{"key":"1756_CR1","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/s40618-016-0560-3","volume":"40","author":"N Mansournia","year":"2017","unstructured":"Mansournia N, Riyahi S, Tofangchiha S, Mansournia MA, Riahi M, Heidari Z, Hazrati E (2017) Subclinical hypothyroidism and diabetic nephropathy in Iranian patients with type 2 diabetes. J Endocrinol Invest 40:289\u2013295. https:\/\/doi.org\/10.1007\/s40618-016-0560-3","journal-title":"J Endocrinol Invest"},{"key":"1756_CR2","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1507\/endocrj.EJ14-0206","volume":"61","author":"S Furukawa","year":"2014","unstructured":"Furukawa S, Yamamoto S, Todo Y, Maruyama K, Miyake T, Ueda T, Niiya T, Senba T, Torisu M, Kumagi T, Miyauchi S, Sakai T, Minami H, Miyaoka H, Matsuura B, Hiasa Y, Onji M, Tanigawa T (2014) Association between subclinical hypothyroidism and diabetic nephropathy in patients with type 2 diabetes mellitus. Endocr J 61:1011\u20131018. https:\/\/doi.org\/10.1507\/endocrj.EJ14-0206","journal-title":"Endocr J"},{"key":"1756_CR3","doi-asserted-by":"publisher","first-page":"e0135233","DOI":"10.1371\/journal.pone.0135233","volume":"10","author":"C Han","year":"2015","unstructured":"Han C, He X, Xia X, Li Y, Shi X, Shan Z, Teng W (2015) Subclinical hypothyroidism and type 2 diabetes: a systematic review and meta-analysis. PLoS ONE 10:e0135233. https:\/\/doi.org\/10.1371\/journal.pone.0135233","journal-title":"PLoS ONE"},{"key":"1756_CR4","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1530\/EJE-12-0703","volume":"168","author":"C Denzer","year":"2013","unstructured":"Denzer C, Karges B, N\u00e4ke A, Rosenbauer J, Schober E, Schwab KO, Holl RW, Initiative DPV, DPV Initiative and the BMBF-Competence Network Diabetes Mellitus (2013) Subclinical hypothyroidism and dyslipidemia in children and adolescents with type 1 diabetes mellitus. Eur J Endocrinol 168:601\u2013608. https:\/\/doi.org\/10.1530\/EJE-12-0703","journal-title":"Eur J Endocrinol"},{"key":"1756_CR5","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1111\/j.1464-5491.2007.02270.x","volume":"24","author":"HS Chen","year":"2007","unstructured":"Chen HS, Wu TE, Jap TS, Lu RA, Wang ML, Chen RL, Lin HD (2007) Subclinical hypothyroidism is a risk factor for nephropathy and cardiovascular diseases in Type 2 diabetic patients. Diabet Med 24:1336\u20131344. https:\/\/doi.org\/10.1111\/j.1464-5491.2007.02270.x","journal-title":"Diabet Med"},{"key":"1756_CR6","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/S0168-8227(99)00044-3","volume":"45","author":"H Ha","year":"1999","unstructured":"Ha H, Kim KH (1999) Pathogenesis of diabetic nephropathy: the role of oxidative stress and protein kinase C. Diabetes Res Clin Pract 45:147\u2013151. https:\/\/doi.org\/10.1016\/S0168-8227(99)00044-3","journal-title":"Diabetes Res Clin Pract"},{"key":"1756_CR7","doi-asserted-by":"publisher","first-page":"383","DOI":"10.5114\/aoms.2017.65479","volume":"13","author":"A Aydogdu","year":"2017","unstructured":"Aydogdu A, Karakas EY, Erkus E, Alt\u0131parmak \u0130H, Sav\u0131k E, Ulas T, Sabuncu T (2017) Epicardial fat thickness and oxidative stress parameters in patients with subclinical hypothyroidism. Arch Med Sci 13:383. https:\/\/doi.org\/10.5114\/aoms.2017.65479","journal-title":"Arch Med Sci"},{"key":"1756_CR8","doi-asserted-by":"publisher","first-page":"2233","DOI":"10.1185\/03007995.2015.1094044","volume":"31","author":"P Liu","year":"2015","unstructured":"Liu P, Liu R, Chen X, Chen Y, Wang D, Zhang F, Wang Y (2015) Can levothyroxine treatment reduce urinary albumin excretion rate in patients with early type 2 diabetic nephropathy and subclinical hypothyroidism? A randomized double-blind and placebo-controlled study. Curr Med Res Opin 31:2233\u20132240. https:\/\/doi.org\/10.1185\/03007995.2015.1094044","journal-title":"Curr Med Res Opin"},{"key":"1756_CR9","doi-asserted-by":"publisher","first-page":"270","DOI":"10.7326\/0003-4819-132-4-200002150-00004","volume":"132","author":"AE Hak","year":"2000","unstructured":"Hak AE, Pols HA, Visser TJ, Drexhage HA, Hofman A, Witteman JC (2000) Subclinical hypothyroidism is an independent risk factor for atherosclerosis and myocardial infarction in elderly women: the Rotterdam Study. Ann Intern Med 132:270\u2013278. https:\/\/doi.org\/10.7326\/0003-4819-132-4-200002150-00004","journal-title":"Ann Intern Med"},{"key":"1756_CR10","doi-asserted-by":"publisher","first-page":"2732","DOI":"10.1210\/jc.2012-1663","volume":"97","author":"DH Shin","year":"2012","unstructured":"Shin DH, Lee MJ, Kim SJ, Oh HJ, Kim HR, Han JH, Koo HM, Doh FM, Park JT, Han SH, Yoo TH, Kang SW (2012) Preservation of renal function by thyroid hormone replacement therapy in chronic kidney disease patients with subclinical hypothyroidism. J Clin Endocrinol Metab 97:2732\u20132740. https:\/\/doi.org\/10.1210\/jc.2012-1663","journal-title":"J Clin Endocrinol Metab"},{"key":"1756_CR11","doi-asserted-by":"publisher","first-page":"e75","DOI":"10.1016\/j.diabres.2011.08.019","volume":"94","author":"T Yasuda","year":"2011","unstructured":"Yasuda T, Kaneto H, Kuroda A, Yamamoto T, Takahara M, Naka T, Miyashita K, Fujisawa K, Sakamoto F, Katakami N, Matsuoka TA, Shimomura I (2011) Subclinical hypothyroidism is independently associated with albuminuria in people with type 2 diabetes. Diabetes Res Clin Pract 94:e75\u2013e77. https:\/\/doi.org\/10.1016\/j.diabres.2011.08.019","journal-title":"Diabetes Res Clin Pract"},{"key":"1756_CR12","doi-asserted-by":"publisher","first-page":"450","DOI":"10.4093\/dmj.2013.37.6.450","volume":"37","author":"MM El-Eshmawy","year":"2013","unstructured":"El-Eshmawy MM, Abd El-Hafez HA, El Shabrawy WO, Abdel Aal IA (2013) Subclinical hypothyroidism is independently associated with microalbuminuria in a cohort of prediabetic egyptian adults. Diabetes Metab J 37:450\u2013457. https:\/\/doi.org\/10.4093\/dmj.2013.37.6.450","journal-title":"Diabetes Metab J"},{"key":"1756_CR13","doi-asserted-by":"crossref","first-page":"405","DOI":"10.2337\/diab.40.4.405","volume":"40","author":"JW Baynes","year":"1991","unstructured":"Baynes JW (1991) Role of oxidative stress in development of complications in diabetes. Diabetes 40:405\u2013412","journal-title":"Diabetes"},{"key":"1756_CR14","doi-asserted-by":"publisher","first-page":"977","DOI":"10.2337\/diab.40.4.405","volume":"1993","author":"Control D, Group CTR","year":"1993","unstructured":"Control D, Group CTR (1993) The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993:977\u2013986. https:\/\/doi.org\/10.2337\/diab.40.4.405","journal-title":"N Engl J Med"},{"key":"1756_CR15","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/0891-5849(91)90040-A","volume":"10","author":"SP Wolff","year":"1991","unstructured":"Wolff SP, Jiang ZY, Hunt JV (1991) Protein glycation and oxidative stress in diabetes mellitus and ageing. Free Radic Biol Med 10:339\u2013352. https:\/\/doi.org\/10.1016\/0891-5849(91)90040-A","journal-title":"Free Radic Biol Med"},{"key":"1756_CR16","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/0891-5849(94)90152-X","volume":"16","author":"H Ha","year":"1994","unstructured":"Ha H, Kim C, Son Y, Chung M-H, Kim KH (1994) DNA damage in the kidneys of diabetic rats exhibiting microalbuminuria. Free Radic Biol Med 16:271\u2013274. https:\/\/doi.org\/10.1016\/0891-5849(94)90152-X","journal-title":"Free Radic Biol Med"},{"key":"1756_CR17","first-page":"A736","volume":"3","author":"H Ha","year":"1997","unstructured":"Ha H, Kim K (1997) Role of protein kinase C-mediated oxidative stress in increased TGF-\u03b21 and fibronectin mRNAs in mesangial cells: implications for diabetic nephropathy. Nephrology 3:A736","journal-title":"Nephrology"},{"key":"1756_CR18","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1681\/ASN.V83426","volume":"8","author":"D Koya","year":"1997","unstructured":"Koya D, Lee I-K, Ishii H, Kanoh H, King GL (1997) Prevention of glomerular dysfunction in diabetic rats by treatment with d-alpha-tocopherol. J Am Soc Nephrol 8:426\u2013435","journal-title":"J Am Soc Nephrol"},{"key":"1756_CR19","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1016\/S0891-5849(98)00276-7","volume":"26","author":"H Ha","year":"1999","unstructured":"Ha H, Yu M-R, Kim KH (1999) Melatonin and taurine reduce early glomerulopathy in diabetic rats. Free Radic Biol Med 26:944\u2013950. https:\/\/doi.org\/10.1016\/S0891-5849(98)00276-7","journal-title":"Free Radic Biol Med"},{"key":"1756_CR20","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1677\/joe.0.1770137","volume":"177","author":"L Oziol","year":"2003","unstructured":"Oziol L, Faure P, Bertrand N, Chomard P (2003) Inhibition of in vitro macrophage-induced low density lipoprotein oxidation by thyroid compounds. J Endocrinol 177:137\u2013146. https:\/\/doi.org\/10.1677\/joe.0.1770137","journal-title":"J Endocrinol"},{"key":"1756_CR21","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1677\/joe.0.1400073","volume":"140","author":"B Pereira","year":"1994","unstructured":"Pereira B, Rosa LC, Safi D, Bechara E, Curi R (1994) Control of superoxide dismutase, catalase and glutathione peroxidase activities in rat lymphoid organs by thyroid hormones. J Endocrinol 140:73\u201377. https:\/\/doi.org\/10.1677\/joe.0.1400073","journal-title":"J Endocrinol"},{"key":"1756_CR22","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1002\/cbf.1031","volume":"21","author":"S Yilmaz","year":"2003","unstructured":"Yilmaz S, Ozan S, Benzer F, Canatan H (2003) Oxidative damage and antioxidant enzyme activities in experimental hypothyroidism. Cell Biochem Funct 21:325\u2013330. https:\/\/doi.org\/10.1002\/cbf.1031","journal-title":"Cell Biochem Funct"},{"key":"1756_CR23","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1159\/000107747","volume":"16","author":"L Kebapcilar","year":"2007","unstructured":"Kebapcilar L, Akinci B, Bayraktar F, Comlekci A, Solak A, Demir T, Yener S, K\u00fcme T, Yesil S (2007) Plasma thiobarbituric acid-reactive substance levels in subclinical hypothyroidism. Med Princ Pract 16:432\u2013436. https:\/\/doi.org\/10.1159\/000107747","journal-title":"Med Princ Pract"},{"key":"1756_CR24","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1111\/j.1365-2265.2008.03348.x","volume":"70","author":"AN Torun","year":"2009","unstructured":"Torun AN, Kulaksizoglu S, Kulaksizoglu M, Pamuk BO, Isbilen E, Tutuncu NB (2009) Serum total antioxidant status and lipid peroxidation marker malondialdehyde levels in overt and subclinical hypothyroidism. Clin Endocrinol (Oxf) 70:469\u2013474. https:\/\/doi.org\/10.1111\/j.1365-2265.2008.03348.x","journal-title":"Clin Endocrinol (Oxf)"},{"key":"1756_CR25","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.ygcen.2012.03.012","volume":"178","author":"S Jena","year":"2012","unstructured":"Jena S, Chainy GBN, Dandapat J (2012) Hypothyroidism modulates renal antioxidant gene expression during postnatal development and maturation in rat. Gen Comp Endocrinol 178:8\u201318. https:\/\/doi.org\/10.1016\/j.ygcen.2012.03.012","journal-title":"Gen Comp Endocrinol"},{"key":"1756_CR26","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1055\/s-2007-981457","volume":"115","author":"G Baskol","year":"2007","unstructured":"Baskol G, Atmaca H, Tanr\u0131verdi F, Baskol M, Kocer D, Bayram F (2007) Oxidative stress and enzymatic antioxidant status in patients with hypothyroidism before and after treatment. Exp Clin Endocrinol Diabetes 115:522\u2013526. https:\/\/doi.org\/10.1055\/s-2007-981457","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"1756_CR27","doi-asserted-by":"publisher","DOI":"10.1007\/s12272-013-0227-y","author":"S Mutlu","year":"2013","unstructured":"Mutlu S, Parlak A, Aydogan U, Aydogdu A, Soykut B, Akay C, Saglam K, Taslipinar A (2013) The effect of levothyroxine replacement therapy on lipid profile and oxidative stress parameters in patients with subclinical hypothyroid. Arch Pharm Res. https:\/\/doi.org\/10.1007\/s12272-013-0227-y","journal-title":"Arch Pharm Res"},{"key":"1756_CR28","doi-asserted-by":"publisher","first-page":"2937","DOI":"10.1681\/ASN.2006040368","volume":"17","author":"YC Ma","year":"2006","unstructured":"Ma YC, Zuo L, Chen JH, Luo Q, Yu XQ, Li Y, Xu JS, Huang SM, Wang LN, Huang W, Wang M, Xu GB, Wang HY (2006) Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease. J Am Soc Nephrol 17:2937\u20132944. https:\/\/doi.org\/10.1681\/ASN.2006040368","journal-title":"J Am Soc Nephrol"}],"container-title":["International Urology and Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11255-017-1756-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-017-1756-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-017-1756-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,9]],"date-time":"2022-08-09T19:36:14Z","timestamp":1660073774000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11255-017-1756-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12,1]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["1756"],"URL":"https:\/\/doi.org\/10.1007\/s11255-017-1756-y","relation":{},"ISSN":["0301-1623","1573-2584"],"issn-type":[{"value":"0301-1623","type":"print"},{"value":"1573-2584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12,1]]}}}